Glioblastomas (GBMs) diffusely infiltrate the brain, making complete removal by surgical resection impossible. The mixture of neoplastic and nonneoplastic cells that remain after surgery form the biological context for adjuvant therapeutic intervention and recurrence. We performed RNA-sequencing (RNA-seq) and histological analysis on radiographically guided biopsies taken from different regions of GBM and showed that the tissue contained within the contrast-enhancing (CE) core of tumors have different cellular and molecular compositions compared with tissue from the nonenhancing (NE) margins of tumors. Comparisons with the The Cancer Genome Atlas dataset showed that the samples from CE regions resembled the proneural, classical, or mesenchy...
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent heterogen...
Glioblastoma (GB) is the most frequent and aggressive type of primary brain tumor. Recurrences are m...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...
Glioblastoma (GB) is a highly invasive primary brain tumor that almost systematically recurs despite...
Laser capture microdissection (LCM) coupled with RNA-seq is a powerful tool to identify genes that a...
Glioblastoma (GBM) are among the most common malignant central nervous system (CNS) cancers, they ar...
International audienceGlioblastoma (GB) is a highly invasive primary brain tumor that almost systema...
Glioblastoma (GB) is a highly infiltrative tumor recurring within a few centimeters of the resection...
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma m...
SummaryThe Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in gliobla...
Background: Glioblastoma is the most aggressive type of brain cancer with high-levels of intra- and ...
Background: Glioblastoma (GB) is a devastating primary brain malignancy. The recurrence of GB is ine...
Glioblastoma (GBM) is the most common and aggressive form of adult primary brain cancer. Therapeutic...
Glioma is the most common primary brain malignancy and remains a challenging and intractable disease...
Background: Glioblastoma (GB) is a devastating primary brain malignancy. The recurrence of GB is i...
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent heterogen...
Glioblastoma (GB) is the most frequent and aggressive type of primary brain tumor. Recurrences are m...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...
Glioblastoma (GB) is a highly invasive primary brain tumor that almost systematically recurs despite...
Laser capture microdissection (LCM) coupled with RNA-seq is a powerful tool to identify genes that a...
Glioblastoma (GBM) are among the most common malignant central nervous system (CNS) cancers, they ar...
International audienceGlioblastoma (GB) is a highly invasive primary brain tumor that almost systema...
Glioblastoma (GB) is a highly infiltrative tumor recurring within a few centimeters of the resection...
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma m...
SummaryThe Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in gliobla...
Background: Glioblastoma is the most aggressive type of brain cancer with high-levels of intra- and ...
Background: Glioblastoma (GB) is a devastating primary brain malignancy. The recurrence of GB is ine...
Glioblastoma (GBM) is the most common and aggressive form of adult primary brain cancer. Therapeutic...
Glioma is the most common primary brain malignancy and remains a challenging and intractable disease...
Background: Glioblastoma (GB) is a devastating primary brain malignancy. The recurrence of GB is i...
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent heterogen...
Glioblastoma (GB) is the most frequent and aggressive type of primary brain tumor. Recurrences are m...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...